Sarepta Therapeutics (NASDAQ:SRPT) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Sarepta Therapeutics beat estimated earnings by 31.86%, reporting an EPS of $-0.77 versus an estimate of $-1.13.
Revenue was up $56.32 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $1.7 which was followed by a 0.51% increase in the share price the next day.
Here's a look at Sarepta Therapeutics's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -1.89 | -1.29 | -1.78 | -1.77 |
| EPS Actual | -0.19 | -1.52 | -1.54 | -1.84 |
| Revenue Estimate | 173.42M | 162.64M | 143.33M | 146.29M |
| Revenue Actual | 189.41M | 164.09M | 146.93M | 145.14M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
